Canakinumab Subcutaneous and Metoprolol Extended-Release Capsules
Determining the interaction of Canakinumab Subcutaneous and Metoprolol Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: metoprolol
Brand name: Kapspargo Sprinkle, Lopressor, Toprol-XL, Toprol XL
Synonyms: Metoprolol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Metoprolol Extended-Release Tablets
- Canakinumab Subcutaneous-Metoprolol Injection
- Canakinumab Subcutaneous-Metoprolol Intravenous
- Canakinumab Subcutaneous-Metoprolol Succinate
- Canakinumab Subcutaneous-Metoprolol Succinate ER Capsules
- Canakinumab Subcutaneous-Metoprolol Succinate ER Tablets
- Metoprolol Extended-Release Capsules-Canasa
- Metoprolol Extended-Release Capsules-Canasa Pac rectal
- Metoprolol Extended-Release Capsules-Canasa rectal
- Metoprolol Extended-Release Capsules-Cancidas
- Metoprolol Extended-Release Capsules-Candesartan
- Metoprolol Extended-Release Capsules-Candesartan and Hydrochlorothiazide